Use of levetiracetam in pediatric refractory status epilepticus
Vol. 8 No. 1 (2019), Case Report
Vol. 8 No. 1 (2019)

Use of levetiracetam in pediatric refractory status epilepticus

Case Report
Published 2019-08-18
Kashyap Narsingh Shakya
Professor; Department of Pediatrics, Kathmandu Medical College, Kathmandu, Nepal.
Anwesh Bhatta
Lecturer; Department of Pediatrics, Kathmandu Medical College, Kathmandu, Nepal.
Samjhana Phuyal
Second year Resident; Department of Pediatrics, Kathmandu Medical College, Kathmandu, Nepal.
Arbind Yadav
First year Resident, Department of Pediatrics, Kathmandu Medical College, Kathmandu, Nepal.
pdf

Keywords

Levetiracetam
Antiepileptic drug
Pediatric refractory seizure

How to Cite

Shakya, K. N., Bhatta, A., Phuyal, S., & Yadav, A. (2019). Use of levetiracetam in pediatric refractory status epilepticus. Journal of Kathmandu Medical College, 8(1), 41–43. Retrieved from https://www.jkmc.com.np/ojs3/index.php/journal/article/view/464
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

Refractory status epilepticus, with persistence of seizures despite initial intravenous benzodiazepine and one secondline intravenous antiepileptic drug occurs in nine percent to 44% of the patients with status epilepticus. Aggressive treatme

pdf